Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000032591
Abstract: Background: The efficacy of tivantinib for MET-high hepatocellular carcinoma remains controversial. We conduct this meta-analysis to explore the efficacy of tivantinib versus placebo for MET-high hepatocellular carcinoma. Methods: We have searched PubMed, EMbase, Web of…
read more here.
Keywords:
met high;
hepatocellular carcinoma;
meta analysis;
high hepatocellular ... See more keywords